Growth Metrics

Soleno Therapeutics (SLNO) Profit After Tax (QoQ) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Soleno Therapeutics 2.76 Bn 2.51 Bn 93.41 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -27.68%
Dec 31, 2025 66.80%
Sep 30, 2025 652.53%
Jun 30, 2025 89.24%
Mar 31, 2025 21.81%
Dec 31, 2024 26.93%
Sep 30, 2024 -250.58%
Jun 30, 2024 -2.13%
Mar 31, 2024 -89.43%
Dec 31, 2023 -4.01%
Sep 30, 2023 -28.15%
Jun 30, 2023 -1.42%
Mar 31, 2023 -52.31%
Dec 31, 2022 10.53%
Sep 30, 2022 8.82%
Jun 30, 2022 -17.49%
Mar 31, 2022 -102.40%
Dec 31, 2021 65.26%
Sep 30, 2021 25.92%
Jun 30, 2021 -22.72%
Mar 31, 2021 -213.96%
Dec 31, 2020 66.62%
Sep 30, 2020 -15.72%
Jun 30, 2020 -26.05%
Mar 31, 2020 59.95%
Dec 31, 2019 -1,745.11%
Sep 30, 2019 108.88%
Jun 30, 2019 -42.36%
Mar 31, 2019 -2,773.00%
Dec 31, 2018 111.39%
Sep 30, 2018 67.29%
Jun 30, 2018 -85.54%
Mar 31, 2018 51.18%
Dec 31, 2017 -212.68%
Sep 30, 2017 18.46%
Jun 30, 2017 -49.44%
Mar 31, 2017 -43.85%
Dec 31, 2016 20.00%
Sep 30, 2016 49.42%
Jun 30, 2016 -10.16%
Mar 31, 2016 -12.11%
Dec 31, 2015 13.62%
Sep 30, 2015 -275.07%
Jun 30, 2015 116.14%
Mar 31, 2015 -61.40%
Dec 31, 2014 -201.66%
Sep 30, 2014 14.32%
Jun 30, 2014 -234.89%
Mar 31, 2014 14.40%
Dec 31, 2013 38.73%